Eidos Therapeutics, Inc. Share Holder Equity 2018-2020 | EIDX
Eidos Therapeutics, Inc. share holder equity from 2018 to 2020. Share holder equity can be defined as the sum of preferred and common equity items
| Eidos Therapeutics, Inc. Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2019 | $171 |
| 2018 | $155 |
| 2017 | $4 |
| 2016 | $1 |
| Eidos Therapeutics, Inc. Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2020-09-30 | $123 |
| 2020-06-30 | $149 |
| 2020-03-31 | $175 |
| 2019-12-31 | $171 |
| 2019-09-30 | $164 |
| 2019-06-30 | $132 |
| 2019-03-31 | $144 |
| 2018-12-31 | $155 |
| 2018-09-30 | $164 |
| 2018-06-30 | $174 |
| 2018-03-31 | $21 |
| 2017-12-31 | $4 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
